These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7784343)

  • 1. Incorporation of first-order uptake rate constants from simple mammillary models into blood-flow limited physiological pharmacokinetic models via extraction efficiencies.
    Roth WL; Weber LW; Rozman KK
    Pharm Res; 1995 Feb; 12(2):263-9. PubMed ID: 7784343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two equally valid interpretations of the linear multicompartment mammillary pharmacokinetic model.
    Jacobs JR; Shafer SL; Larsen JL; Hawkins ED
    J Pharm Sci; 1990 Apr; 79(4):331-3. PubMed ID: 2352145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitions and applications of mean transit and residence times in reference to the two-compartment mammillary plasma clearance model.
    Kong AN; Jusko WJ
    J Pharm Sci; 1988 Feb; 77(2):157-65. PubMed ID: 3361431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological significance of the rate constants in compartmental analysis.
    Charkes ND
    Nucl Med Commun; 2001 Mar; 22(3):331-9. PubMed ID: 11314767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Compartment simulation models and physiologic use in pharmaco- and toxicokinetics].
    Kostrzewski P
    Med Pr; 1998; 49(1):83-92. PubMed ID: 9587914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncertainties in physiologically based pharmacokinetic models caused by several input parameters.
    Jang JY; Droz PO; Chung HK
    Int Arch Occup Environ Health; 1999 Jul; 72(4):247-54. PubMed ID: 10491779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulation of differential drug pharmacokinetics under heat and exercise stress using a physiologically based pharmacokinetic modeling approach.
    Sidhu P; Peng HT; Cheung B; Edginton A
    Can J Physiol Pharmacol; 2011 May; 89(5):365-82. PubMed ID: 21627485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting age-appropriate pharmacokinetics of six volatile organic compounds in the rat utilizing physiologically based pharmacokinetic modeling.
    Rodriguez CE; Mahle DA; Gearhart JM; Mattie DR; Lipscomb JC; Cook RS; Barton HA
    Toxicol Sci; 2007 Jul; 98(1):43-56. PubMed ID: 17426107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of a generic physiologically based pharmacokinetic model for children.
    Edginton AN; Schmitt W; Willmann S
    Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of PBPK Model-Calculation of Drug Time Course in Tissue Using IV Bolus Drug Plasma Concentration-Time Profile and the Physiological Parameters of the Organ.
    Berezhkovskiy LM
    J Pharm Sci; 2016 Aug; 105(8):2453-8. PubMed ID: 27290628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analytical solution set for a four-compartment mixed mammillary/catenary model.
    Charkes ND; Siegel JA
    Nucl Med Commun; 1999 Jun; 20(6):575-80. PubMed ID: 10451871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro simulation of in vivo pharmacokinetic model with intravenous administration via flow rate modulation.
    Chen YC; Liang W; Hu JL; He GL; Wu XJ; Liu XF; Zhang J; Hu XQ
    J Pharmacokinet Pharmacodyn; 2015 Feb; 42(1):33-43. PubMed ID: 25354895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically relevant one-compartment pharmacokinetic models for skin. 1. Development of models.
    McCarley KD; Bunge AL
    J Pharm Sci; 1998 Apr; 87(4):470-81. PubMed ID: 9548901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of changes in the clinical pharmacokinetics of basic drugs on the basis of octanol-water partition coefficients.
    Ishizaki J; Yokogawa K; Nakashima E; Ichimura F
    J Pharm Pharmacol; 1997 Aug; 49(8):762-7. PubMed ID: 9379352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural identifiability of physiologically based pharmacokinetic models.
    Yates JW
    J Pharmacokinet Pharmacodyn; 2006 Aug; 33(4):421-39. PubMed ID: 16568353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An introduction to physiologically-based pharmacokinetic models.
    Upton RN; Foster DJ; Abuhelwa AY
    Paediatr Anaesth; 2016 Nov; 26(11):1036-1046. PubMed ID: 27550716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of biosolubility on pulmonary uptake and disposition of gases and vapors of lipophilic chemicals.
    Fiserova-Bergerova V; Tichy M; Di Carlo FJ
    Drug Metab Rev; 1984; 15(5-6):1033-70. PubMed ID: 6396052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The upper and lower bounds of rate constants for general mammillary compartment systems.
    Lam CF; Chung A
    J Pharmacokinet Biopharm; 1983 Jun; 11(3):289-301. PubMed ID: 6644554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A valid equation for the well-stirred perfusion limited physiologically based pharmacokinetic model that consistently accounts for the blood-tissue drug distribution in the organ and the corresponding valid equation for the steady state volume of distribution.
    Berezhkovskiy LM
    J Pharm Sci; 2010 Jan; 99(1):475-85. PubMed ID: 19492340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.